The American authority FDA has approved the use of a ‘bionisch eye’. The oogprothese that are a part of the sight to the blind, to recover, must be ge lwa mplanteerd in patient clients.
The Argus II Retinal Prosthesis System received a green light from the Food and Drug Administration. The system, consisting of a camera, transmitter, beeldverwerkingselektronica and a netvliesimplantaat exists, should patients be used. The device restores a portion of vision in patients with the hereditary disease retinitis pigmentosa. About one in four thousand people would have this malady, in which the peripheral and night vision disappear, and later also normal vision reduces.
The patient must have intact optic nerve; the implant contains electrodes, which are cells in the retina to electrical stimulation. The signals in the brain to be interpreted and translated into form and movement. The Argus II system has already been successfully tested in completely blind subjects, which is a part of their vision recovered.
The Argus OO Retinal Prosthesis System was by several cooperating laboratories and research institutes developed. It consists of a camera on a pair of sunglasses is mounted. The recorded images are processed to simplified to the electrodes to be passed. The electrodes stimulate cells in the retina. The current model has 60 electrodes, but a version with more than 200 electrodes is already working. The ultimate goal would be to have the vision of patients in such a way to recover that they even can read.